Abstract
A 36-year-old woman was referred to our hospital because of splenomegaly in February 1989. The leukocyte count was 55,500/μl without hiatus leukemicus. The leukocyte alkaline phosphatase score was low (29). The bone marrow showed myeloid hyperplasia (24.8% myeloblasts) but no dysplastic change. The karyotype of the bone marrow cells was 46, XX and a diagnosis of Ph1 (-) CML was made. Treatment with VCR, 6MP and prednisolone made 7-month-durated chronic phase. but the abnormal karyotype [46, XX, i(17q)] gradually increased to 100% of bone marrow cells. The patient died in June 1990.
The evidence that not only a BCR rearrangement but also messages of BCR/ABL fusion gene were negative made us able to differentiate this case from Ph1 (-), BCR (+) CML. The addition of an i(17q) results in partial monosomy of 17q (17q13; p53 gene) and partial trisomy of 17q (17q11.2-12; G-CSF gene). We examined the rearrangement of p53 gene and G-CSF-dependent tumor cell growth in vitro, demonstrating one allelic loss of p53 gene and independent cell growth on G-CSF respectively. It is thought that in Ph1 (-), BCR (-) CML as well as in Ph1 (+) CML, an i(17q) is related to the progression but not to the initiation of these leukemias. However the precise mechanism, including p53 gene inactivation by point mutation, is still to be elucidated.
